CRVS icon

Corvus Pharmaceuticals
CRVS

Overview Fund Activity

53 hedge funds and large institutions have $250M invested in Corvus Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 0 closing their positions.

Holders
53
Holders Change
+8
Holders Change %
+17.78%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
15
Reduced
16
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$32.9M
2
EAM
2
EverPoint Asset Management
Connecticut
$5.98M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$3.67M
4
EIM
4
Essex Investment Management
Massachusetts
$304K
5
BFA
5
BlackRock Fund Advisors
California
$1.56M

Top Sellers

1
BA
1
BlackRock Advisors
Delaware
$398K
2
ACA
2
Avoro Capital Advisors
New York
$3.1M
3
Millennium Management
3
Millennium Management
New York
$842K
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$8.76M
5
CAM
5
Cormorant Asset Management
Massachusetts
$2.84M
Name Holding Trade Value Shares
Change 		Shares
Change %
Barclays
51
Barclays
United Kingdom
$2K +$1.74K +139 +662%
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$2K +$2K +158 New
BNP Paribas Financial Markets
53
BNP Paribas Financial Markets
France
$615 -$2.6K -182 -81%
1 2
3